Fundz
Back to SEC Filings
10-QMEDIUM RiskDETERIORATING

ANGIODYNAMICS INC

www.angiodynamics.com
Filed: Apr 2, 2026 CIK: 0001275187Health Care
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

AngioDynamics shows concerning deterioration with significantly worsening operating losses, declining cash position, and persistent unprofitability despite revenue growth. The company's operating loss increased 30% year-over-year while cash burned down $18M, raising questions about financial sustainability.

Red Flags Detected (6)

Operating loss increased 30% to $12.9M vs $10.0M prior year despite 8.9% revenue growth

Cash position declined significantly from $55.9M to $37.8M (32% decrease)

Net loss per share worsened from $0.11 to $0.19 (73% increase)

3 more red flags detected

Key Takeaways

Revenue growth of 8.9% unable to offset rapidly increasing operating expenses

Operating margin compression indicates fundamental business model challenges

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateApr 2, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence85%
Red Flags6

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings